Pushing the envelope in genomics technologies – innovation and leadership from Bio-Rad
Learn how Bio-Rad has continually responded to researchers’ needs to drive innovation in its genomics technologies over the past 30 years
Learn how Bio-Rad has continually responded to researchers’ needs to drive innovation in its genomics technologies over the past 30 years
LG Chem selects second and third drug targets following rapid progress in first program
Sartorius Intellicyt addresses challenges such as high cost and purification difficulties and presents possible solutions
Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers
Polymer chemists can now perform analyses on a single system that conventionally required multiple instruments and retrofitting
Bio-Rad launches iQ-check real-time PCR kit for detection of Aspergillus in cannabis and cannabis-infused products
Addressing the challenges of daily food quality control inspections
Multiplexed immunofluorescence and next-generation image analysis offer spatial insights into the tumor microenvironment
Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago
Watch this webinar to discover the innovation taking place within the FTIR spectroscopy field, leading to novel capabilities for a wide variety of industry applications
Newly discovered antibodies promise significant improvement over current therapies
Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection
Paragon Genomics announced the two products at the 2019 Association for Molecular Pathology (AMP)
Dr. Angela Smirnova discusses her work on microbial ecology, including how the concept of ‘bioremediation’ could help to tackle greenhouse gas emissions with microbes
Watch this webinar to find out how to automate your NGS workflow for cancer diagnostics and personalized medicine
Hitachi and the Centre Leon Berard Cancer Center to launch research into diagnosis and treatment
Envigo enters CRISPR gene-edited research model field with the addition of Horizon’s business
Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Metrology capabilities expanded with the installation of new WDXRF and micro-CT systems